As the cancer inhibitory effects of metformin are cancer cell-autonomous and depend on its ability to inhibit mCI, the refractoriness of SHMT2-KO HAP1 cells to metformin might reflect the requirement for SHMT2 for proper mitochondrial metabolic functioning including the assembly of mCI [57,58,59]. Here, SHMT2 is linked to cancer.